Peritoneal dialysis in children: Challenges for the new millennium

被引:4
作者
Flynn, JT
Warady, BA
机构
[1] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat & Communicable Dis, Div Pediat Nephrol, Ann Arbor, MI 48109 USA
[2] Childrens Mercy Hosp, Dept Pediat, Sect Pediat Nephrol, Kansas City, MO 64108 USA
来源
ADVANCES IN RENAL REPLACEMENT THERAPY | 2000年 / 7卷 / 04期
关键词
peritoneal dialysis; children; peritonitis; growth failure; dialysis kinetics;
D O I
10.1053/jarr.2000.16271
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Advances in technology and experience accumulated over the past 2 decades have resulted in the ability to successfully provide chronic peritoneal dialysis (PD) to children of all ages and sizes. However, many important clinical issues remain, including uncertainty regarding the "optimal" dialysis dose for children, the treatment of growth retardation associated with renal insufficiency, prevention of peritonitis, and the challenge of caring for newborn infants with end-stage renal disease (ESRD). This article summarizes current knowledge in each of these 4 areas, highlighting not only the advances of the past quarter-century, but also the questions that persist as we initiate the new millennium. The outcome of children receiving PD will be markedly improved only when ongoing acid future research efforts reveal the optimal solutions to these important issues. (C) 2000 by the National Kidney Foundation, inc.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 75 条
[1]  
ALEXANDER SR, 1993, KIDNEY INT, V43, pS65
[2]  
ALEXANDER SR, 1984, END STAGE RENAL DISE, P17
[3]   Adverse effect of peritonitis on peritoneal membrane function in children on dialysis [J].
Andreoli, SP ;
Leiser, J ;
Warady, BA ;
Schlichting, L ;
Brewer, ED ;
Watkins, SL .
PEDIATRIC NEPHROLOGY, 1999, 13 (01) :1-6
[4]  
[Anonymous], 1997, AM J KIDNEY DIS S, V30, pS67
[5]   PROTEIN AND LIPID-METABOLISM IN NEPHROTIC INFANTS ON PERITONEAL-DIALYSIS AFTER NEPHRECTOMY [J].
ANTIKAINEN, M .
PEDIATRIC NEPHROLOGY, 1993, 7 (04) :428-433
[6]  
Baumann G, 1996, PEDIATR NEPHROL, V10, P328
[7]   A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin [J].
Bernardini, J ;
Piraino, B ;
Holley, J ;
Johnston, JR ;
Lutes, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) :695-700
[8]  
BREWER ED, 1990, ADV PERIT D, V6, P269
[9]  
Bro S, 1997, PERITON DIALYSIS INT, V17, P554
[10]  
Bunchman T E, 1996, Perit Dial Int, V16 Suppl 1, pS505